The EMA's main advisory committee has backed approval of Novo Nordisk's oral GLP-1 agonist Rybelsus, a key pipeline drug in its type 2 diabetes franchise. Rybelsus (semaglutide) is the first GLP-1 ...

When it comes to achieving weight loss goals, women often face unique challenges. From hormonal fluctuations to busy lifestyles, finding a solution that works can be daunting. However, the combination ...

Why Choose Sokolove Law as Your New Hampshire Medical Malpractice Law Firm? At Sokolove Law, we understand the devastating impact that medical negligence can have on your life. Our New Hampshire ...

When Jim Sokolove founded Sokolove Law in 1979, his mission was to make the justice system more accessible to people from all walks of life. Since then, we’ve helped thousands of people take legal ...